We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Tea Drinking Significantly Reduces Risk of Stroke

By LabMedica International staff writers
Posted on 04 Mar 2009
A recently published study reviewed the experimental evidence linking tea drinking and stroke and concluded that drinking at least three cups of tea a day significantly reduces stroke risk.

Investigators from the University of California, Los Angeles (UCLA; USA) searched the Internet for all studies on stroke and tea consumption in humans with original data, including estimation or measurement of tea consumption and outcomes of fatal or nonfatal stroke. More...
Data from nine studies involving 4,378 strokes among 194,965 individuals were pooled.

Results published in the February 19, 2009, online edition of Stroke, a Journal of the American Heart Association, revealed that regardless of their country of origin, individuals consuming at least three cups of tea per day had a 21% lower risk of stroke than those consuming less than one cup per day. The tea could be black or green as long it was from the classical tea plant Camellia sinensis and not an herbal tea.

So far, researchers have failed to identify the compounds in tea responsible for the stroke-reducing effect. Speculation points to the antioxidant epigallocatechin gallate (EGCG) or the amino acid theanine. Theanine is especially interesting, as it is related to glutamine and can cross the blood-brain barrier. Since it can enter the brain, theanine has psychoactive properties. Theanine has been shown to reduce mental and physical stress and produce feelings of relaxation.

"What we saw was that there was a consistency of effect of appreciable magnitude,” said first author Dr. Lenore Arab, professor of biological chemistry at the University of California, Los Angeles. "By drinking three cups of tea a day, the risk of a stroke was reduced by 21%. It did not matter if it was green or black tea. That is why these findings are so exciting. If we can find a way to prevent the stroke, or prevent the damage, that is simple and not toxic, that would be a great advance. We do know that theanine is nearly 100% absorbed. It gets across the blood-brain barrier and it looks a lot like a molecule that is very similar to glutamate, and glutamate release is associated with stroke. It could be that theanine and glutamate compete for the glutamate receptor in the brain.”

Related Links:
University of California, Los Angeles




Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Automatic Western Blot Analyzer
Tenfly Phoenix Blot Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.